Moderna Plans To Start Phase 3 Testing of its COVID-19 Vaccine Candidate in July

On June 11, biotech company Moderna announced it had finalized plans for phase 3 testing of its COVID-19 vaccine candidate. The late-stage trial will include 30,000 participants and is expected to begin in July.